Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML
Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.
Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedLocations section added, listing Baden-Wurttemberg and Lower Saxony as study sites. HHS Vulnerability Disclosure and location-specific pages for Baden-Wurttemberg and Lower Saxony were removed.SummaryDifference0.3%
- Check50 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. No visible changes to the study page content or layout.SummaryDifference0.1%
- Check57 days agoChange DetectedAdded an editorial note that publications are provided voluntarily by the person entering information about the study and updated the revision tag to v3.3.1. The previous statement asserting that publications are about the study results was removed.SummaryDifference0.1%
- Check65 days agoChange DetectedRemoved the funding-lapse disclaimer banner from the study page, which previously warned that information may not be up to date.SummaryDifference0.4%
- Check79 days agoChange DetectedNo additions or deletions were detected in the page content.SummaryDifference0.5%
- Check108 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%
Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML
Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.